Observational studyAnnals of the rheumatic diseases2017

Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus.

Md Yuzaiful Md Yusof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.